116 related articles for article (PubMed ID: 24283997)
1. Diabetes mellitus and non-muscle-invasive bladder cancer: not just a coincidence?
Cresswell J
BJU Int; 2013 Dec; 112(8):1055-6. PubMed ID: 24283997
[No Abstract] [Full Text] [Related]
2. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
3. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
4. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
5. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
[TBL] [Abstract][Full Text] [Related]
6. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
Taneja SS
J Urol; 2014 Jun; 191(6):1783. PubMed ID: 25280280
[No Abstract] [Full Text] [Related]
7. Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
Weckermann D
Eur Urol; 2014 Jul; 66(1):174-5. PubMed ID: 24929079
[No Abstract] [Full Text] [Related]
8. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
[TBL] [Abstract][Full Text] [Related]
9. [What Is the effect of metformin combined to chemotherapy in stage IV colorectal cancer with diabetes?].
Jung JT
Korean J Gastroenterol; 2012 Dec; 60(6):343-4. PubMed ID: 23367542
[No Abstract] [Full Text] [Related]
10. [Results of treatment of adult diabetes mellitus with Metformin-sulfonamide combination (apropos of 197 cases)].
Debry G; Laurent J
J Med Lyon; 1966 Mar; 47(94):407-13. PubMed ID: 5909923
[No Abstract] [Full Text] [Related]
11. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?
Zanders MM; Vissers PA; van de Poll-Franse LV
J Clin Oncol; 2014 Mar; 32(7):701. PubMed ID: 24395861
[No Abstract] [Full Text] [Related]
12. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.
Dhouib N; Turki Z; Mellouli F; Ouederni M; Yahiaoui S; Nagi S; Ben Slama C; Bejaoui M
Tunis Med; 2010 Feb; 88(2):136. PubMed ID: 20415181
[No Abstract] [Full Text] [Related]
13. [Anti-oncogenic effect of metformin].
Noto H
Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
[No Abstract] [Full Text] [Related]
14. Metformin as Initial Oral Therapy in Type 2 Diabetes.
Stern RJ; Murphy EJ
JAMA; 2015 Jun 23-30; 313(24):2484-5. PubMed ID: 26103032
[No Abstract] [Full Text] [Related]
15. A pharmacist's perspective on metformin use and cancer outcomes.
Ceacareanu AC
J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
[No Abstract] [Full Text] [Related]
16. [Type 2 diabetes: Metformin: first choice at the start of therapy].
Gallwitz B
Dtsch Med Wochenschr; 2015 Feb; 140(4):236. PubMed ID: 25704514
[No Abstract] [Full Text] [Related]
17. Initial therapy for diabetes mellitus.
Segal JB; Maruthur NM
JAMA Intern Med; 2014 Dec; 174(12):1962-3. PubMed ID: 25347083
[No Abstract] [Full Text] [Related]
18. Metformin as an addition to conventional chemotherapy in breast cancer.
Grenader T; Goldberg A; Shavit L
J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
[No Abstract] [Full Text] [Related]
19. Metformin and mortality.
Lund SS
Diabetologia; 2013 Apr; 56(4):937-8. PubMed ID: 23377620
[No Abstract] [Full Text] [Related]
20. Metformin does not improve survival of cholangiocarcinoma patients with diabetes.
Yang Z; Zhang X; Roberts RO; Roberts LR; Chaiteerakij R
Hepatology; 2016 Feb; 63(2):667-8. PubMed ID: 25833233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
